Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008
Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008

NCT01903733

CompletedNA

Sponsor: Pfizer

Conditions: Chronic Myeloid Leukemia

Interventions: bosutinib

Countries: United States, Argentina, Australia, Belgium, Brazil, Canada, Chile, China

The objective of the study is to provide long term access to bosutinib treatment and assess long term safety, tolerability and duration of clinical benefit, without any formal hypothesis testing; therefore, there is no formal primary endpoint.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Only subjects previously participating in two specific studies are eligible to enroll into this study. Enrollment is not open to subjects if not previously enrolled in studies B1871006 or B1871008.

Exclusion Criteria:

* All subjects are excluded unless previously participating in studies B1871006 or B1871008.
Locations (91)
  • Orlando, Florida, United States
  • Atlanta, Georgia, United States
  • Atlanta, Georgia, United States
  • Atlanta, Georgia, United States
  • Atlanta, Georgia, United States
  • Atlanta, Georgia, United States
  • Indianapolis, Indiana, United States
  • Sioux City, Iowa, United States
  • Bethesda, Maryland, United States
  • Hawthorne, New York, United States
  • Hershey, Pennsylvania, United States
  • Houston, Texas, United States
  • Houston, Texas, United States
  • Cd. Autonoma de Buenos Aires, Buenos Aires, Argentina
  • La Plata, Buenos Aires, Argentina
  • Corrientes, Argentina
  • Herston, Queensland, Australia
  • Adelaide, South Australia, Australia
  • Charleroi, Belgium
  • Campinas, São Paulo, Brazil
  • Santo André, São Paulo, Brazil
  • Edmonton, Alberta, Canada
  • Vancouver, British Columbia, Canada
  • Toronto, Ontario, Canada
  • Montreal, Quebec, Canada
  • Reñaca, Valparaiso, Chile
  • Reñaca, Valparaiso, Chile
  • Beijing, Beijing Municipality, China
  • Hangzhou, Zhejiang, China
  • Beijing, China
  • + 61 more on CT.gov